Novartis cannot block drugmaker MSN Pharmaceuticals from launching a generic version of its blockbuster heart-failure drug ...

Receiving six or more prescriptions of the drug gabapentin for low back pain is associated with significantly increased risks ...

Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can effectively combat Epstein-Barr virus (EBV)-driven lymphomas. The findings, ...

Structure−activity relationships in rhesus monkeys for a novel mixed-onium class of ultra-short-acting nondepolarizing tetrahydroisoquinolinium neuromuscular blockers (NMBs) are described. Bis-onium ...

Senzime’s neuromuscular monitoring solution, TetraGraph system receives US patent: Uppsala, Sweden Thursday, July 3, 2025, 16:00 Hrs [IST] Uppsala-headquartered Senzime, a leadi ...

UPPSALA, SWEDEN / ACCESS Newswire / July 1, 2025 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced it has secured a contract to supply TetraGraph monitors and enter a scientific collaboration with ...

UPPSALA, SWEDEN / ACCESS Newswire / July 1, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF), today announced that the United States Patent and Trademark Office (USPTO) has issued a new patent protecting and ...

Neuromuscular blocking agents are considered high-alert drugs because misuse can lead to catastrophic injuries or death. These drugs should be given your highest attention, just as you've done ...

Neuromuscular blocking agents have been inadvertently administered to patients who were not receiving proper ventilator assistance. Because the respiratory muscles were paralyzed, some patients ...

Blocking these pathways with currently available drugs effectively killed melanoma cells. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.

Capricor receives FDA Orphan Drug Designation for Deramiocel, targeting Becker Muscular Dystrophy while advancing Duchenne Muscular Dystrophy application.